Among seven patients with MMR-proficient (MMR-P) locally advanced rectal cancer who underwent neoadjuvant chemotherapy, there was a significant increase PD-1 positive T cells in the biopsy specimen obtained after chemotherapy compared to the one before treatment (43). The gene discussed is PDCD1; the disease is rectal cancer.